FR2628972B1 - PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND METHOD FOR PREPARING THEM - Google Patents

PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND METHOD FOR PREPARING THEM

Info

Publication number
FR2628972B1
FR2628972B1 FR8903812A FR8903812A FR2628972B1 FR 2628972 B1 FR2628972 B1 FR 2628972B1 FR 8903812 A FR8903812 A FR 8903812A FR 8903812 A FR8903812 A FR 8903812A FR 2628972 B1 FR2628972 B1 FR 2628972B1
Authority
FR
France
Prior art keywords
cardiac
preparing
pharmaceutical compositions
cardiovascular system
compositions acting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8903812A
Other languages
French (fr)
Other versions
FR2628972A1 (en
Inventor
Nagy Peter Literati
Radvany-Nee-Hegedues Erzsebet
Boros Maria
Szilbereky Jeno
Blasko Gyoergy
Gachalyi Bela
Hamar-Nee-Nemes Gizella
Nemeth Gabor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOREX KFT
Original Assignee
BIOREX KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOREX KFT filed Critical BIOREX KFT
Publication of FR2628972A1 publication Critical patent/FR2628972A1/en
Application granted granted Critical
Publication of FR2628972B1 publication Critical patent/FR2628972B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
FR8903812A 1988-03-23 1989-03-23 PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND METHOD FOR PREPARING THEM Expired - Fee Related FR2628972B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Publications (2)

Publication Number Publication Date
FR2628972A1 FR2628972A1 (en) 1989-09-29
FR2628972B1 true FR2628972B1 (en) 1994-09-23

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8903812A Expired - Fee Related FR2628972B1 (en) 1988-03-23 1989-03-23 PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND METHOD FOR PREPARING THEM

Country Status (15)

Country Link
JP (1) JPH0222228A (en)
KR (1) KR890014104A (en)
BE (1) BE1003021A3 (en)
CA (1) CA1319607C (en)
CH (1) CH677732A5 (en)
DE (1) DE3909707A1 (en)
ES (1) ES2014060A6 (en)
FI (1) FI891438A (en)
FR (1) FR2628972B1 (en)
GB (1) GB2216421A (en)
HU (1) HU210122B (en)
IT (1) IT1229205B (en)
LU (1) LU87488A1 (en)
NL (1) NL8900742A (en)
SE (1) SE8901041L (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (en) * 1990-11-06 2000-12-04 ソニー株式会社 Electronics
KR19990015198A (en) * 1997-08-02 1999-03-05 손남율 Vegetable antibiotics
BE1012495A3 (en) 1999-03-02 2000-11-07 Messadek Jallal Glycine betaine-for its use antithrombotic.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (en) * 2000-11-08 2005-04-01 Brif NEW DIETETIC AND / OR COSMETIC COMPOSITIONS FOR IMPROVING MUCOUS DROUGHT
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
BR0309740A (en) * 2002-05-03 2005-02-22 Pronova Biocare As Use of eicosapentaenoic acid (epa), docosaexaenoic acid (dha) or a mixture of epa and dha or a pharmaceutically acceptable salt or derivative thereof
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (en) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition for regulation and cellular regeneration in the digestive tract, useful e.g. for treating gastroenteritis or improving animal performance, comprises essential oils, shark liver oil, selenium and water
EP1776159A1 (en) * 2004-08-09 2007-04-25 Enzymotec Ltd. Food products for diabetics
JP5118965B2 (en) 2004-08-10 2013-01-16 エンジモテック リミテッド Treatment methods that require plant components
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (en) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Antiviral and immunostimulant pharmaceutical composition containing polyunsaturated fatty acid esters
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
CN101180073A (en) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 Insulins combinations
ITMI20052483A1 (en) * 2005-12-23 2007-06-24 Novamont Spa BIODEGRADABLE LURES
FR2935394B1 (en) 2008-08-29 2013-03-08 Eco Solution ORGANIC SELENIUM-ENRICHED PHOTOSYNTHETIC MICROORGANISMS FROM SELENO-HYDROXYACID COMPOUNDS AND THEIR USE IN NUTRITION, COSMETICS AND PHARMACY
FR2935393B1 (en) 2008-08-29 2012-08-24 Tetrahedron ORGANIC SELENIUM ENRICHED BACTERIA AND YEASTS FROM SELENO-HYDROXYACID COMPOUNDS AND THEIR NUTRITION, COSMETIC AND PHARMACY APPLICATIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
HU202088B (en) * 1987-03-18 1991-02-28 Caola Kozmetikai Method for producing dietetic preparation
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition

Also Published As

Publication number Publication date
IT1229205B (en) 1991-07-25
FI891438A0 (en) 1989-03-23
DE3909707A1 (en) 1989-10-05
HU210122B (en) 1995-02-28
FR2628972A1 (en) 1989-09-29
BE1003021A3 (en) 1991-10-29
GB2216421A (en) 1989-10-11
SE8901041L (en) 1989-09-24
IT8919876A0 (en) 1989-03-23
HUT60436A (en) 1992-09-28
CH677732A5 (en) 1991-06-28
KR890014104A (en) 1989-10-21
FI891438A (en) 1989-09-24
SE8901041D0 (en) 1989-03-23
NL8900742A (en) 1989-10-16
CA1319607C (en) 1993-06-29
ES2014060A6 (en) 1990-06-16
GB8906856D0 (en) 1989-05-10
LU87488A1 (en) 1990-10-02
JPH0222228A (en) 1990-01-25

Similar Documents

Publication Publication Date Title
FR2628972B1 (en) PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND METHOD FOR PREPARING THEM
NL193218B (en) Method for the preparation of stainless steel.
NL970020I2 (en) Cinoline derivatives and methods for their preparation.
FR2628324B1 (en) ANTIVIRAL AND IMMUNOSTIMULANT PHARMACEUTICAL COMPOSITIONS AND PROCESS FOR PREPARING THE SAME
NL193652B (en) Sweet delicacy and method for its preparation.
FR2618788B1 (en) COPOLYMER SEQUENCE AND PROCESS FOR PREPARING THE SAME
FR2663326B2 (en) PYRIDAZINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
EP0520987A4 (en) METHOD OF SUPPRESSING APPETITE BY ADMINISTRATION OF TETRAHYDRO--g(b)-CARBOLINE DERIVATIVES.
FR2612399B1 (en) PHARMACEUTICAL COMPOSITIONS ACTING ON THE HEART AND CARDIOVASCULAR SYSTEM AND METHOD FOR THEIR PREPARATION
IT1216139B (en) DIETARY COMPOSITION AND PROCEDURE FOR ITS PREPARATION.
MA21984A1 (en) PROCESS FOR THE PREPARATION OF QUILINONE DERIVATIVES.
IT8720985A0 (en) HYDROPHILIC COPOLYMER AND METHOD FOR ITS PRODUCTION.
FR2663813B1 (en) METHOD AND MEANS FOR THE FORMATION OF CULTURE TUNNELS.
FR2576900B1 (en) 2-SUBSTITUTED CYCLOHEPTO-IMIDAZOLE DERIVATIVES, ANTI-ULCER AGENTS AND PROCESS FOR THEIR PREPARATION
FR2653998B1 (en) INJECTABLE SOLUTION AND PROCESS FOR PREPARING THE SAME.
FR2604356B1 (en) MULTI-LAYERED TRANSDERMAL PHARMACEUTICAL COMPOSITIONS HAVING LONG-TERM EFFECT AND PROCESS FOR PREPARING THE SAME
IT8719700A0 (en) 2-THIOMETHYL-SUSTITUTED-PYRIDINES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT1243739B (en) L-CARNITINA DEHYDROGENASE AND PROCEDURE FOR ITS PRODUCTION.
IT8621632A0 (en) BROMOFLUROETHYLIPOFLUORATE AND PROCEDURE FOR ITS PREPARATION.
FR2643081B1 (en) MAGNESIUM FOLATES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS
NL193192B (en) Oxicam derivative, pharmaceutical preparation containing the derivative and method for preparing oxicam derivatives.
FI891391A0 (en) SAOG MED VERTICAL RAM.
ITRM920813A0 (en) EPITHELIUM-TUBULAR SUPPORT BIOSTRUCTURE AND METHOD FOR ITS PREPARATION.
FR2586180B3 (en) METHOD FOR PRODUCING AN ARTICULATED REST FURNITURE AND FURNITURE OBTAINED BY THE METHOD
IT1216894B (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION.

Legal Events

Date Code Title Description
ST Notification of lapse